SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-111983
Filing Date
2020-10-05
Accepted
2020-10-05 08:00:56
Documents
17
Period of Report
2020-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032171d1_8k.htm 8-K 18072
2 EXHIBIT 99.1 tm2032171d1_ex99-1.htm EX-99.1 15264
3 GRAPHIC image_02.jpg GRAPHIC 5687
4 GRAPHIC slide-01.jpg GRAPHIC 61940
5 GRAPHIC slide-02.jpg GRAPHIC 82528
6 GRAPHIC slide-03.jpg GRAPHIC 70227
7 GRAPHIC slide-04.jpg GRAPHIC 54714
8 GRAPHIC slide-05.jpg GRAPHIC 65076
9 GRAPHIC slide-06.jpg GRAPHIC 61313
10 GRAPHIC slide-07.jpg GRAPHIC 48663
11 GRAPHIC slide-08.jpg GRAPHIC 63670
12 GRAPHIC slide-09.jpg GRAPHIC 58094
13 GRAPHIC slide-10.jpg GRAPHIC 60733
14 GRAPHIC slide-11.jpg GRAPHIC 42539
15 GRAPHIC slide-12.jpg GRAPHIC 51406
16 GRAPHIC slide-13.jpg GRAPHIC 45381
17 GRAPHIC slide-14.jpg GRAPHIC 87643
  Complete submission text file 0001104659-20-111983.txt   1216094
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 201222345
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences